Androgen deprivation therapy - Managing side effects

被引:0
|
作者
Kabir, Shahrir [1 ]
Mancuso, Pascal
Rashid, Prem [2 ,3 ]
机构
[1] Royal N Shore Hosp, Sydney, NSW, Australia
[2] Port Macquarie Base Hosp, Port Macquarie, NSW, Australia
[3] Univ New S Wales, Rural Clin Sch, Port Macquarie, NSW, Australia
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Prostate cancer is the most common nondermatologic cancer in Australian men. Androgen deprivation therapy (ADT) as a modality of treatment is being increasingly used much earlier and for a longer period of time. Its various regimens all have side effects which influence the. patient's health and quality of life. Objective This article discusses practical evidence based management options for treating the short and long term side effects of ADT. Discussion The side effects of ADT can be categorised as Sexual, physical, metabolic, emotional and systemic. A combination of prediction and early recognition is useful in diagnosing side effects. Tailored strategies are available to combat the problems
引用
收藏
页码:641 / 646
页数:6
相关论文
共 50 条
  • [21] Management of breast side-effects in men treated with androgen deprivation therapy
    Lewis, Rachel
    Khan, Atia
    Payne, Heather
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2013, 4 (04) : 40 - 42
  • [22] The role of exercise in managing the adverse effects of androgen deprivation therapy in men with prostate cancer
    Murphy, Robyn
    Wassersug, Richard
    Dechman, Gail
    [J]. PHYSICAL THERAPY REVIEWS, 2011, 16 (04) : 269 - 277
  • [23] Metabolic effects of androgen deprivation therapy
    Choi, See Min
    Kam, Sung Chul
    [J]. KOREAN JOURNAL OF UROLOGY, 2015, 56 (01) : 12 - 18
  • [24] STAYING STRONG AND HEALTHY: MINIMIZING CARDIOVASCULAR AND METABOLIC SIDE EFFECTS OF ANDROGEN DEPRIVATION THERAPY
    Maliski, Sally
    Hamilton-Reeves, Jill
    Billinger, Sandra
    Thrasher, Brantley
    Enslein, Alana
    [J]. ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [25] Effects of androgen deprivation therapy on telomere length
    Cheung, Ada S.
    Yeap, Bu B.
    Hoermann, Rudolf
    Hui, Jennie
    Beilby, John P.
    Grossmann, Mathis
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 87 (04) : 381 - 385
  • [26] Metabolic and cardiovascular effects of androgen deprivation therapy
    Hakimian, Payam
    Blute, Michael, Jr.
    Kashanian, James
    Chan, Sherman
    Silver, David
    Shabsigh, Ridwan
    [J]. BJU INTERNATIONAL, 2008, 102 (11) : 1509 - 1514
  • [27] Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
    Grossmann, Mathis
    Zajac, Jeffrey D.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 74 (03) : 289 - 293
  • [28] Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer
    Cormie, Prue
    Zopf, Eva M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (02) : 62 - 70
  • [29] Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer
    Atalar, Kerem
    Rajan, Prabhakar
    [J]. NATURE REVIEWS UROLOGY, 2023, 20 (01) : 3 - 4
  • [30] Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer
    Kerem Atalar
    Prabhakar Rajan
    [J]. Nature Reviews Urology, 2023, 20 : 3 - 4